Stability of an extemporaneously prepared bleomycin–lidocaine–epinephrine intradermal admixture used in dermatology

Kateb, Nabil El; Chaussard, Michael; Bellenger, Patrice; Petit, Antoine; Pierre, Faure

doi:10.1177/1078155214526267

Search citation statements

Order By: Relevance

Paper Sections

Select...

Cyclophosphamide Suspension1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results found satisfied for both simple syrup and in Oraplus concluding the shelf life of the prepared suspensions 8 and 3 days, respectively [6].…”

Section: Cyclophosphamide Suspensionsupporting

confidence: 50%

An Overview on Stability of Extemporaneously Prepared Pharmaceutical Suspension

Naveed¹,

Akhtar²,

Khan³

2017

J Bioequiv Availab

View full text Add to dashboard Cite

“…The results found satisfied for both simple syrup and in Oraplus concluding the shelf life of the prepared suspensions 8 and 3 days, respectively [6].…”

Section: Cyclophosphamide Suspensionsupporting

confidence: 50%

An Overview on Stability of Extemporaneously Prepared Pharmaceutical Suspension

Naveed¹,

Akhtar²,

Khan³

2017

J Bioequiv Availab

View full text Add to dashboard Cite

SFPO and ESOP recommendations for the practical stability of anticancer drugs: second update

D'Huart,

Astier,

Bardin

et al. 2024

European Journal of Oncology Pharmacy

View full text Add to dashboard Cite

A second update of the recommendations for the practical stability of anticancer drugs published in 2013 has been realized by the French Society of Hospital Pharmacists (SFPO); European Society of Oncology Pharmacists (ESOP); and members of the Stabilis® database (www.stabilis.org), a stability and compatibility database of drugs. Forty-six new molecules have been included. These new data make it possible to optimize anticancer drug preparations and achieve product savings. These new recommendations have to be taken into consideration only if the preparation is made according to the Good Manufacturing Practices in classified rooms.

show abstract

Stability of an extemporaneously prepared bleomycin–lidocaine–epinephrine intradermal admixture used in dermatology

Abstract: A maximum of three days storage at 4℃ and only one day at 22℃ was approved for BLE.

Cited by 2 publications

References 21 publications

An Overview on Stability of Extemporaneously Prepared Pharmaceutical Suspension

An Overview on Stability of Extemporaneously Prepared Pharmaceutical Suspension

SFPO and ESOP recommendations for the practical stability of anticancer drugs: second update

Contact Info

Product

Resources

About